OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 61 filers reported holding OVID THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,389 | +17.1% | 62,341 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $204,478 | +24.3% | 62,341 | -2.2% | 0.00% | 0.0% |
| Q1 2023 | $164,452 | -46.8% | 63,741 | -61.6% | 0.00% | -50.0% |
| Q4 2022 | $308,837 | -65.1% | 166,041 | -24.6% | 0.00% | -71.4% |
| Q1 2021 | $886,000 | +918.4% | 220,357 | +482.3% | 0.01% | +600.0% |
| Q4 2020 | $87,000 | -62.8% | 37,843 | -7.1% | 0.00% | -50.0% |
| Q3 2020 | $234,000 | +22.5% | 40,717 | -48.5% | 0.00% | -33.3% |
| Q4 2018 | $191,000 | -1.0% | 79,094 | +131.9% | 0.00% | 0.0% |
| Q3 2018 | $193,000 | – | 34,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |